An Explainer On The FDA’s Rejection Of MDMA Treatment For PTSD
Many investors and researchers have been predicting a psychedelics boom, with MDMA being just the first of a number of psychedelics in the drug development pipeline.
Many investors and researchers have been predicting a psychedelics boom, with MDMA being just the first of a number of psychedelics in the drug development pipeline.
On the cost of psilocybin, adult versus medical programs, and FDA developments. Based on “interviews with facilitators, service center owners, manufacturers, researchers and policymakers in Oregon.”
View this profile on InstagramTalking Joints Memo (@tjmlive) • Instagram photos and videos
Sign up for Talking Joints Memo newsletter